Cymat Technologies (CYM) AI Stock Analysis

Cymat Technologies

(TSXV:CYM)

Select Model

Rating:46Neutral

Price Target:CAD 0.08▼(-2.35% Downside)

Action:reiterated

Date:10/28/26

The score is driven primarily by severe financial weakness, including negative equity, high debt, ongoing losses, and sustained cash burn. Positive revenue momentum and favorable price positioning provide some support, but overbought momentum and an unprofitable valuation remain significant risks.

Positive Factors

Revenue reboundThe sharp TTM revenue rebound indicates stronger customer demand and improving commercial traction for Cymat’s cellular metal products. If sustained, higher volumes can improve operating leverage, support production scaling, and broaden the company’s ability to fund investment from business growth.

Negative Factors

Negative equity and leverageNegative equity indicates that accumulated losses have eroded Cymat’s capital base, while sizeable debt increases financial pressure relative to its modest asset base. This combination reduces balance-sheet flexibility and may constrain the company’s ability to absorb setbacks or finance expansion internally.

Cymat Technologies (CYM) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 8.53M
Dividend Yield: ―
Average Volume (3M): 56.58K
Price to Earnings (P/E): -1.8
Beta (1Y): 0.44
Revenue Growth: 67.87%
EPS Growth: 13.49%
Country: Canada
Employees: 11
Sector: General
Sector Strength: 55
Industry: Manufacturing - Metal Fabrication

Cymat Technologies Business Overview & Revenue Model

Company Description

Cymat Technologies Ltd. is a global materials science enterprise primarily engaged in the creation and sale of advanced stabilized aluminum foam products. The company offers its architectural-grade materials under the Alusion brand, while its SmartMe...

How the Company Makes Money

Cymat makes money primarily by selling its proprietary cellular metal materials and related manufactured products to customers that use these materials in their own products or engineering solutions. Key revenue streams include (1) product sales of c...

Cymat Technologies Financial Statement Overview

Summary

Revenue growth and improving gross margins are outweighed by substantial operating and net losses, deeply negative equity, rising debt, and persistent negative operating and free cash flow.

Income Statement

28Negative

Balance Sheet

9Very Negative

Cash Flow

20Very Negative

Financial statement breakdown
Breakdown	TTM	Jul 2026	Jul 2025	Jul 2024	Jul 2023	Jul 2021
Income Statement
Total Revenue	1.91M	1.91M	3.71M	1.62M	3.05M	3.12M
Gross Profit	-38.49K	-39.85K	494.39K	-412.85K	-270.42K	795.48K
EBITDA	-2.46M	-2.44M	-1.91M	-3.34M	-5.45M	-4.23M
Net Income	-4.88M	-4.88M	-3.37M	-4.27M	-6.05M	-4.75M
Balance Sheet
Total Assets	3.24M	3.24M	2.76M	3.96M	4.16M	6.17M
Cash, Cash Equivalents and Short-Term Investments	161.55K	161.55K	354.03K	56.27K	324.05K	2.47M
Total Debt	6.79M	6.79M	5.58M	2.94M	2.28M	1.02M
Total Liabilities	9.60M	9.60M	7.49M	6.78M	4.77M	3.83M
Stockholders Equity	-6.37M	-6.37M	-4.73M	-2.81M	-612.07K	2.34M
Cash Flow
Free Cash Flow	-2.34M	-2.34M	-1.64M	-2.26M	-3.49M	-4.53M
Operating Cash Flow	-2.26M	-2.26M	-1.60M	-2.23M	-2.46M	-4.32M
Investing Cash Flow	-82.34K	-82.34K	-37.52K	-31.32K	-1.03M	-534.54K
Financing Cash Flow	2.13M	2.13M	1.93M	1.99M	1.18M	2.30M

Cymat Technologies Technical Analysis

Technical Analysis SentimentNegative

Last Price0.09

Price Trends

50DMA0.10Negative

100DMA0.10Negative

200DMA0.09Negative

Market Momentum

MACD0.00Negative

RSI42.89Neutral

STOCH42.59Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CYM, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.10, and below the 200-day MA of 0.09, indicating a bearish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 42.89 is Neutral, neither overbought nor oversold. The STOCH value of 42.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CYM.

Cymat Technologies Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TSE:CYM against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:DRX	78Outperform	CAD 466.56M	12.87	16.61%	0.24%	29.57%	-7.54%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TSE:CYM	46Neutral	CAD 8.53M	-1.77	83.25%	―	67.87%	13.49%
TSE:USCU	39Underperform	CAD 13.31M	-9.44	-103.21%	―	―	-7.89%
TSE:IB	38Underperform	CAD 12.13M	-3.92	-239.91%	―	8.84%	36.67%
TSE:MTS	37Underperform	CAD 9.58M	-3.22	-321.65%	―	―	-206.25%

* General Sector Average

Performance Comparison

TSE:CYM and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:CYM	Cymat Technologies	0.09	-0.02	-19.05%
TSE:USCU	US Copper Corp	0.09	-0.02	-19.05%
TSE:DRX	ADF Group Inc. SV	16.34	9.22	129.37%
TSE:IB	IBC Advanced Alloys	0.10	-0.12	-52.27%
TSE:MTS	Metallis Resources	0.10	-0.33	-77.65%

Cymat Technologies Corporate Events

Business Operations and Strategy

KAP Minerals and Cymat Technologies Plan Canadian Scandium-Aluminum Alloy Venture

Positive

Oct 28, 2026

KAP Minerals Inc. and Cymat Technologies have signed a memorandum of understanding to form a joint venture that would produce scandium-aluminum master alloy in Canada, using scandium oxide from KAP’s Northern Ontario project and Cymat’s f...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026

Cymat Technologies AI Stock Analysis